Active, not recruitingPhase 1NCT05315661

The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia

Studying Frontotemporal dementia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Samsung Medical Center
Principal Investigator
HeeJin Kim
Samsung Medical Center
Intervention
ET-STEM(drug)
Enrollment
12 enrolled
Eligibility
40-85 years · All sexes
Timeline
20222026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05315661 on ClinicalTrials.gov

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

See all trials for Frontotemporal dementia

← Back to all trials